A company developing treatments for disease by restoring the natural balance of bacteria on the skin received a patent for its acne therapy using spray-on live bacteria. . . . → Read More: Patent Awarded for Live Bacterial Acne Treatment
|
|||||
|
|
The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies  Comments are closed  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, Europe, genomics, licensing, life sciences, pharmaceuticals, U.K. The European Patent Office announced its intent to award a patent on treatments for nerve cell damage based on the peptide thymosin beta 4. . . . → Read More: Patent Set for Peptide Nerve Damage Treatments Comments are closed Intellectual property biomedical, clinical trials, Europe, heart disease, life sciences, patent, pharmaceuticals, USPTO Technology executives at pharmaceutical and medical device enterprises in the U.S. say financial and intellectual property assets are their top targets for hackers, according to survey results released today. . . . → Read More: Life Science Execs: Financial, IP Info Top Hacker Targets Comments are closed Intellectual property, Regulations computer science, engineering, health care, medical device, pharmaceuticals, software, statistics Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system. . . . → Read More: Lilly Licensing Autoimmune Therapy in $400M Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, clinical trials, licensing, life sciences, pharmaceuticals A company making blood filtering devices was awarded a patent for a process to capture tiny particles carrying proteins that suppress immune responses. . . . → Read More: Patent Awarded for Exosome Capture Process One comment - (Comments are closed) Intellectual property biomedical, cancer, clinical trials, engineering, life sciences, medical device, patent, physical sciences, USPTO A company making treatments for viral infections that stimulate natural T-cells in the immune system is licensing a related technology from Baylor College of Medicine. . . . → Read More: Biotech Licensing Viral T-Cell Immunotherapies One comment - (Comments are closed) Intellectual property biomedical, biotechnology, licensing, life sciences, pharmaceuticals, university One of the key inventors of a genome editing technique known as Crispr is joining a program that promises to ease licensing of its patents for the technology. . . . → Read More: Broad Institute in Crispr Licensing Program One comment - (Comments are closed) Intellectual property biomedical, biotechnology, Europe, genomics, licensing, life sciences, patent, university, USPTO The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products. . . . → Read More: Supreme Court Cuts Biosimilar Waiting Time Comments are closed Intellectual property, Regulations biomedical, biotechnology, cancer, FDA, life sciences, patent, pharmaceuticals |
A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2017 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
